Aspirin
- Generic Name
- Aspirin
- Brand Names
- Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
- Drug Type
- Small Molecule
- Chemical Formula
- C9H8O4
- CAS Number
- 50-78-2
- Unique Ingredient Identifier
- R16CO5Y76E
- Background
Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...
- Indication
Pain, fever, and inflammation
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke
- Associated Therapies
- Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention
First Real-World Data for Resmetirom Use in Clinical Practice
Real-world data from 72 MASH patients prescribed resmetirom at 2 US centers show consistency with phase 3 trial results, indicating potential for replicating efficacy in clinical practice.
FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You
FDA proposes to ban oral phenylephrine from OTC drugs due to ineffectiveness in treating nasal congestion, despite its common use in cold medications. Public comment period open until May 7, 2025, with no safety concerns cited. Proposal does not affect nasal spray form. Alternatives include nasal sprays, oral pseudoephedrine, and antihistamine nasal sprays.
Clindamycin and bacterial load reduction as prophylaxis for surgical site infection
A trial in Tropical North Queensland aims to reduce surgical site infections (SSI) in skin cancer surgery below the knee using oral clindamycin and preoperative chlorhexidine wash with nasal mupirocin. This double-blind, placebo-controlled study will compare three arms: bacterial load reduction, clindamycin, and standard care. The primary outcome is SSI incidence, with secondary measures including adverse reactions and antibiotic resistance patterns. The trial seeks to improve patient outcomes and promote antibiotic stewardship.
What You Need to Know About FluMist, the Nasal Flu Vaccine
FluMist, a nasal flu vaccine approved for at-home use by the FDA, contains weakened flu virus strains and is effective for ages 2-49. It offers a good immune response but isn't suitable for immunocompromised individuals or those with lung disease. It will be available for home use in fall 2025.
FDA: Off-label use of aspirin in lactating dairy cattle is prohibited
The FDA prohibits using aspirin to treat pyrexia and pain in lactating dairy cattle, as no aspirin products for cattle are FDA-approved. Flunixin meglumine is the sole FDA-approved medication for managing pyrexia and inflammation in such cattle. Veterinarians must use FDA-approved drugs and establish extended withdrawal periods for treated animals.
Abbott starts new trial to assess early use benefit of HeartMate 3
Abbott launches TEAM-HF trial to identify heart failure patients suitable for early HeartMate 3 LVAD therapy, aiming to improve survival rates and quality of life by remotely monitoring pulmonary artery pressures.
FDA warns against use of unapproved aspirin in lactating dairy cattle
FDA warns against using unapproved aspirin to treat pyrexia and pain in lactating dairy cattle, especially those infected with HPAI H5N1. Flunixin meglumine is the only FDA-approved drug for such use, while Vazalore is approved under specific conditions. Extralabel use of unapproved drugs is prohibited, and veterinarians must establish a valid veterinarian-client-patient relationship for approved drug use.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath